Skip to content

Comparison of Bone Cement Application Techniques in Total Knee Arthroplasty Using 3D MAR-CT and Avizo: A Randomized Controlled Trial

Comparison of Bone Cement Application Techniques in Total Knee Arthroplasty Using 3D MAR-CT and Avizo: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122224
Enrollment
Unknown
Registered
2026-04-10
Start date
2026-04-30
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Total Knee Arthroplasty

Interventions

treatment group:Bone surface + prosthesis surface covered with bone cement
control group:Bone surface covered with bone cement only

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age 50–75 years, unilateral primary TKA, primary knee osteoarthritis (Kellgren-Lawrence Grade III–IV); 2. Adequate bone stock at distal femur/proximal tibia (bone mineral density T-score >= -2.5), no bone defects (<=2mm); 3. No cement allergy or coagulation disorders; able to complete follow-up visits and MAR-CT scans; 4. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Revision TKA, bilateral simultaneous TKA, or combined with other joint surgeries; 2. Preoperative knee deformity (valgus/varus >15°) or ligament insufficiency requiring a restrictive prosthesis; 3. History of prior knee surgery, osteomyelitis, or infectious arthritis; 4. Psychiatric disorders, cognitive impairment, or inability to cooperate with 3D quantitative analysis.

Design outcomes

Primary

MeasureTime frame
Bone Cement Penetration Depth;Percentage of interface contact area;Interface gap width and distribution uniformity;

Secondary

MeasureTime frame
Actual intraoperative bone cement usage;Operative duration and incidence of postoperative adverse events (infection, bleeding, deep vein thrombosis, etc.);Postoperative clinical functional recovery;

Countries

China

Contacts

Public ContactZeng Yi

West China Hospital, Sichuan University

zengyi51@scu.edu.cn+86 189 8060 2289

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026